NYSCF Innovators Derive Microglia From Stem Cells
Your body is full of immune cells that fight off infection and illness. You’ve probably heard of a few of them: white blood cells, B cells,...
29 Results
Clear Filters
NYSCF Innovator Shows Nerve Cells Resist Transforming Into Other Cell Types
NYSCF – Robertson Stem Cell Investigator Alumnus and NYSCF – Robertson Stem Cell Prize recipient Dr. Marius Wernig of Stanford University published exciting results showing that nerve...
Five Women Unite to Crack the Code of Multiple Sclerosis
In a collaborative tour de force, five female principal investigators, including NYSCF’s own Dr. Valentina Fossati, are uncovering the cellular mechanisms behind multiple sclerosis (MS). Over...
Dr. Oz Exposes Bogus Stem Cell Treatments
NYSCF Chief of Staff David McKeon appeared on the Dr. Oz Show investigation “Exposing Experimental Stem Cell Treatments.” The segment highlighted the dangers of unproven stem...
NYSCF Research Institute Teams Up With National Stem Cell Foundation to Advance Neurodegeneration Research
The National Stem Cell Foundation (NSCF) and the NYSCF Research Institute announced that a grant from NSCF will be used to fund NYSCF research on cell...
NYSCF Highlights Stem Cell Technology for Multiple Sclerosis Research in Paris
NYSCF Principal Investigator Dr. Valentina Fossati shared how stem cell technology has revolutionized multiple sclerosis research during the session on remyelination at the Multiple Sclerosis Meeting...
NYSCF Team Uses The Power of Stem Cells To Understand Brain Cell Development
NYSCF Principal Investigator Dr. Valentina Fossati and a team of NYSCF Research Institute scientists continued to unravel the mysteries of multiple sclerosis with her latest paper...
Spotlighting International Multiple Sclerosis Awareness Month
NYSCF spoke with Dr. Valentina Fossati who leads NYSCF’s multiple sclerosis research on the future of MS treatments and how stem cells have changed the field...
NYSCF Scientists Accelerate Multiple Sclerosis Research With New Protocol
NYSCF Principal Investigator Dr. Valentina Fossati and NYSCF – Druckenmiller Postdoctoral Fellow Dr. Panagiotis Douvaras have improved a method for deriving oligodendrocyte progenitor cells – the types...
NYSCF – Robertson Investigator Makes Advances in Multiple Sclerosis Research
NYSCF – Robertson Stem Cell Investigator Dr. Paul Tesar, Case Western Reserve School of Medicine, and a team of scientists discovered that two drugs, one used...
NYSCF Scientists One Step Closer to Cell Replacement Therapies for MS
For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they...
Dr. Marius Wernig Awarded 4th Annual NYSCF – Robertson Stem Cell Prize
NYSCF announced that Dr. Marius Wernig, of Stanford University, is the recipient of the NYSCF – Robertson Stem Cell Prize. Dr. Wernig and his team discovered...
NYSCF Multiple Sclerosis Research Featured in Neurology Today
Neurology Today featured NYSCF – Helmsley Investigator Dr. Valentina Fossati’s latest research on multiple sclerosis in a larger story about Dr. Fossati and her personal commitment...
NYSCF Travels Out East to Discuss Latest Research
In conjunction with the Alzheimer’s Disease Resource Center (ADRC), NYSCF presented their latest Alzheimer’s research at the Jewish Center of the Hamptons in East Hampton. Presentations...
NYSCF Announces 2014 Class of NYSCF – Druckenmiller Fellows
NYSCF welcomed the 2014 class of NYSCF – Druckenmiller Postdoctoral Fellows at a reception at the Asia Society. These seven exceptional scientists work in stem cell...
First Disease-Specific Stem Cell Line by SCNT
A team of scientists led by the NYSCF Research Institute’s Dr. Dieter Egli report the first ever patient-specific, diploid (i.e. with two sets of chromosomes, the...
Scientists Upend 160 Years of Neuroanatomy With New Finding
NYSCF – Robertson Stem Cell Investigator Dr. Paola Arlotta, of Harvard University, has made an exciting breakthough and paradigm shift in the basic understanding of neuroanatomy....
Stem Cell Therapy Treatment for Multiple Sclerosis Approved by FDA for Stage I Clinical Trial
In an exciting new development, the Food and Drug Administration (FDA) has approved a new stem cell-derived treatment for a phase I clinical trial in the...
Shining a Light on MS: NYSCF Investigator Profiled
Multiple Sclerosis Discovery Forum followed NYSCF — Helmsley Investigator Valentina Fossati, PhD, on her quest that is as scientific as personal. When she turned 30, Fossati was diagnosed...
NYSCF Investigators Generate New Cells to Study Multiple Sclerosis: A Conversation with Paul Tesar and Marius Wernig
At our annual Innovator's retreat, our 2010 NYSCF — Robertson Stem Cell Investigators Paul Tesar, PhD, of Case Western University, and Marius Wernig, MD, PhD, of...
Skin Cells Transformed to Repair Multiple Sclerosis Damage
Multiple sclerosis, an autoimmune disease in which immune cells attack the fatty protective layer of myelin cells, may have a potential treatment. Through stem cell techniques,...
Dr. Fossati’s Work Opens a Window into MS
Dr. Valentina Fossati conducts research in The New York Stem Cell Foundation Laboratory to unlock the mysteries of multiple sclerosis (MS), a disease that affects...
Winter Research Update
Four NYSCF-supported researchers published exciting new research in major scientific journals this fall. In the November 6th issue of Nature, Jae-won Shim, PhD, a NYSCF –...
Multiple Sclerosis Research Center of New York Announces Clinical Trial for Multiple Sclerosis
11/21/11 The Multiple Sclerosis Research Center of New York (MSRCNY) and the International Cellular Medicine Society (ICMS) jointly announced today the ICMS Institutional Review Board’s (IRB)...
Susan L. Solomon to Speak on ‘State of Industry’ of Regenerative Medicine at Biotech Showcase in San Francisco
Susan L. Solomon to Speak on ‘State of Industry’ of Regenerative Medicine at Biotech Showcase in San Francisco NEW YORK, NY (January 9, 2012) – Susan L....